Losartan potassium and Pneumothorax - a phase IV clinical study of FDA data

Summary:

Pneumothorax is reported as a side effect among people who take Losartan potassium (losartan potassium), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Omeprazole, and have Idiopathic pulmonary fibrosis.

The phase IV clinical study analyzes which people have Pneumothorax when taking Losartan potassium. It is created by eHealthMe based on reports of 50,026 people who have side effects when taking Losartan potassium from the FDA, and is updated regularly.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,511 Losartan potassium users. Check the latest studies of Losartan potassium.

What is Pneumothorax?

Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung) is found to be associated with 1,256 drugs and 1,345 conditions by eHealthMe. Check the latest studies of Pneumothorax.

On Jul, 09, 2026

50,026 people reported to have side effects when taking Losartan potassium.
Among them, 74 people (0.15%) have Pneumothorax.

Could Losartan potassium cause Pneumothorax?

Among these 74 people:

How long have people been on Losartan potassium when they have Pneumothorax? *

What is the gender of people who have Pneumothorax when taking Losartan potassium? *

female: 52.24 %
male: 47.76 %

What is the age of people who have Pneumothorax when taking Losartan potassium? *

What are other drugs people take besides Losartan potassium? *

What are other side effects people have besides Pneumothorax? *

Pneumonia: 23 people, 31.08%
Malaise (a feeling of general discomfort or uneasiness): 18 people, 24.32%
Pain: 17 people, 22.97%
Urinary Tract Infection: 17 people, 22.97%
Fatigue (feeling of tiredness): 16 people, 21.62%
Pleural Effusion (water on the lungs): 16 people, 21.62%
Weight Decreased: 13 people, 17.57%
Dyspnea (difficult or laboured breathing): 12 people, 16.22%
Itching: 10 people, 13.51%
Dizziness: 10 people, 13.51%

What are the existing conditions these people have? *

Idiopathic Pulmonary Fibrosis (chronic lung disease): 9 people, 12.16%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 10.81%
Pain: 8 people, 10.81%
Asthma: 5 people, 6.76%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 5 people, 6.76%
High Blood Cholesterol: 5 people, 6.76%
Renal Cell Carcinoma (a kidney cancer): 4 people, 5.41%
Diabetes: 4 people, 5.41%
Stress And Anxiety: 4 people, 5.41%
Interstitial Lung Disease: 3 people, 4.05%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan potassium and have Pneumothorax?

- Check whether Pneumothorax is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Losartan potassium:

Losartan potassium (51,511 reports)

Pneumothorax treatments and more:

Pneumothorax (19,143 reports)

Browse all side effects of Losartan potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumothorax:

Pneumothorax (1,256 drugs)

Browse all the conditions that are associated with Pneumothorax:

Pneumothorax (1,345 conditions)

Related publications that referenced our studies

Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium (the active ingredients of Losartan potassium) and Losartan potassium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.